Impact BioMedical Stock Forecast - Accumulation Distribution
| IBO Stock | USD 0.47 0.01 2.08% |
Impact Stock Forecast is based on your current time horizon. Although Impact BioMedical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Impact BioMedical's systematic risk associated with finding meaningful patterns of Impact BioMedical fundamentals over time.
As of today the rsi of Impact BioMedical's share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Impact BioMedical hype-based prediction, you can estimate the value of Impact BioMedical from the perspective of Impact BioMedical response to recently generated media hype and the effects of current headlines on its competitors.
Impact BioMedical after-hype prediction price | USD 0.46 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Impact BioMedical to cross-verify your projections. Impact BioMedical Additional Predictive Modules
Most predictive techniques to examine Impact price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Impact using various technical indicators. When you analyze Impact charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 2634.0 | 391.67 |
| Check Impact BioMedical Volatility | Backtest Impact BioMedical | Information Ratio |
Impact BioMedical Trading Date Momentum
| On January 23 2026 Impact BioMedical was traded for 0.47 at the closing time. Highest Impact BioMedical's price during the trading hours was 0.48 and the lowest price during the day was 0.47 . The net volume was 18.8 K. The overall trading history on the 23rd of January did not cause price change. The trading delta at closing time to current price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Impact BioMedical to competition |
Other Forecasting Options for Impact BioMedical
For every potential investor in Impact, whether a beginner or expert, Impact BioMedical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Impact Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Impact. Basic forecasting techniques help filter out the noise by identifying Impact BioMedical's price trends.Impact BioMedical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Impact BioMedical stock to make a market-neutral strategy. Peer analysis of Impact BioMedical could also be used in its relative valuation, which is a method of valuing Impact BioMedical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Impact BioMedical Market Strength Events
Market strength indicators help investors to evaluate how Impact BioMedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Impact BioMedical shares will generate the highest return on investment. By undertsting and applying Impact BioMedical stock market strength indicators, traders can identify Impact BioMedical entry and exit signals to maximize returns.
| Accumulation Distribution | 391.67 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 0.48 | |||
| Day Typical Price | 0.47 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
Impact BioMedical Risk Indicators
The analysis of Impact BioMedical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Impact BioMedical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting impact stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.82 | |||
| Standard Deviation | 7.33 | |||
| Variance | 53.75 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Impact BioMedical
The number of cover stories for Impact BioMedical depends on current market conditions and Impact BioMedical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Impact BioMedical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Impact BioMedical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Impact BioMedical Short Properties
Impact BioMedical's future price predictability will typically decrease when Impact BioMedical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Impact BioMedical often depends not only on the future outlook of the potential Impact BioMedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Impact BioMedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.8 M | |
| Cash And Short Term Investments | 2 M |
Check out Historical Fundamental Analysis of Impact BioMedical to cross-verify your projections. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical's value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical's market value can be influenced by many factors that don't directly affect Impact BioMedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.